"Despite how common this procedure is, the standard of care hasn't changed. And that's created a need for disruption in a market worth nearly $5 billion annually. TriAgenics is pioneering a new approach to wisdom teeth care. Instead of removing wisdom teeth after they become a problem, the company aims to prevent these troublesome teeth entirely. The company's Zero3 TBA is a patented, minimally invasive treatment designed to stop wisdom teeth from ever forming."
"Providing Zero3 treatment could give dental offices a new revenue stream. A general dentist performing just 10 procedures per month could add as much as $300,000 in annual revenue, the company says. Zero3 is preventive care. Anyone between 6-12 years old is a potential candidate for treatment. Now, TriAgenics says it is approaching a critical milestone. The company is preparing to move through FDA review."
Wisdom tooth removal typically requires surgery, anesthesia, recovery and generates unexpected costs, while dentists lose care control and revenue by referring patients to oral surgeons. The market for wisdom tooth removal and care is nearly $5 billion annually with about five million procedures. TriAgenics developed Zero3 TBA, a patented, minimally invasive, one-minute preventive treatment that stops wisdom teeth from forming and can be performed by general dentists without surgery. Zero3 targets patients aged 6–12. Clinics performing ten procedures monthly could add up to $300,000 in annual revenue. TriAgenics is preparing for FDA review, creating an investment inflection point.
Read at Entrepreneur
Unable to calculate read time
Collection
[
|
...
]